Live Quote · NASDAQNPCEHealthcare· Medical - Devices

NeuroPace, Inc.

$16.14 2.35%(+$0.37)
TickerSpark Score
59/100
Mixed
33
Valuation
40
Profitability
100
Growth
64
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NPCE research report →

52-Week Range71% of range
Low
$7.56
Current
$16.14
High
$19.60
Company Overviewwww.neuropace.com

About the company

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy.

CEO
Joel D. Becker
IPO
2021
Employees
203
HQ
Mountain View, CA, US

Price Chart

+54.89% · this period
$19.29$13.77$8.25Jul 02Dec 31Jul 02
Valuation
Market Cap
$550.27M
P/E
-24.77
P/S
5.53
P/B
37.65
EV/EBITDA
-43.78
Div Yield
0.00%
Profitability
Gross Margin
78.29%
Op Margin
-16.84%
Net Margin
-21.67%
ROE
-120.74%
ROIC
-19.74%
Growth & Income
Revenue
$99.99M · 25.13%
Net Income
$-21,465,000 · 20.91%
EPS
$-0.66 · 29.03%
Op Income
$-16,338,000
FCF YoY
37.89%
Performance & Tape
52W High
$19.60
52W Low
$7.56
50D MA
$16.35
200D MA
$14.56
Beta
1.89
Avg Volume
182.71K

Get TickerSpark's AI analysis on NPCE

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 24, 26Morrell Marthaother335
Jun 19, 26Geiger Uriother789
Jun 19, 26Fischer Frank Mother1,467
Jun 19, 26Kumar Rakhiother989
Jun 5, 26Huennekens R Scottother5,368
Jun 5, 26Huennekens R Scottother2,890
Jun 5, 26Fischer Frank Mother2,890
Jun 5, 26Fischer Frank Mother5,368
Jun 5, 26Geiger Uriother2,890
Jun 5, 26Geiger Uriother5,368
Coverage · NPCE

Our NPCE coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on NPCE yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate NPCE report →
Internal Compare

Similar companies

Peers in the same neighborhood.